|
|
||||||||
Department of Integrative Medical Biology, Section for Histology and Cell Biology, Umeå University, Umeå S-901 87, Sweden
(Requests for offprints should be addressed to N Gustavsson; Email: natalia.gustavsson{at}histocel.umu.se)
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Adult female lean and Umeå ob/ob mice were from a local colony and female db/db mice (BKS.Cg-m+/+Leprdb) were from Taconic Europe, Ry, Denmark. db/db mice were brought to our animal care facility at the age of 6 weeks and were housed until 34 months old, when the diabetic condition becomes manifest, but not prolonged. Principles of laboratory animal care (National Institute of Health publication no. 83-25, revised 1985) were followed and the animal care and experimental procedures were carried out in accordance with the standards established by the European Communities Council Directive (86/609/EEC9). The experiments were also approved by the Northern Swedish Committee for Ethics in Animal Experiments.
In overnight-fasted db/db mice, the blood sugar level was 22±2 mM (mean±S.D., n=33). This is in line with earlier observations (Berglund et al. 1978, Gustavsson et al. 2005). The urinary glucose level was 17±2 mM (n=33). The blood sugar in overnight-fasted ob/ob mice was 7±0.4 mM (n=16), with negative urinary glucose. The blood sugar level of lean mice was 5±0.4 mM (n=15).
ß-Cell preparation
Single ß-cells were prepared by shaking collagenase-isolated islets in Ca2+-deficient medium supplemented with EGTA and DNAase (Roche, Mannheim, Germany) (Lernmark 1974). The cells were distributed on polylysine-coated cover glasses (Sigma Chemicals, Stockholm, Sweden) placed in Petri dishes and maintained in tissue culture for 2448 h at 11.1 mM glucose in medium (RPMI 1640; Roche) supplemented with 10% heat-inactivated fetal calf serum (Gibco, Stockholm, Sweden), 60 mg/ml garamycin (Schering Co., Kenilworth, NJ, USA), 60 mg/ml benzylpenicillin (Schering Co.), and 2 mM L-glutamine (Labkemi AB, Stockholm, Sweden). Subsequent experimental handling was performed with a KrebsRinger medium (KRH, Gibco) having the following composition in mM: 130 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, and 2.56 CaCl2 and supplemented with 1 mg/ml BSA (Sigma Chemicals) and 3 mM D-glucose (Larsson-Nyrén & Sehlin 1996). The medium was buffered with 20 mM HEPES (Roche) and NaOH to pH of 7.4 and equilibrated with ambient air.
Measurements of cytoplasmic Ca2+ with Fura-2
Isolated cells were loaded with 1 µM Fura-2 (Molecular Probes Inc., Eugene, Oregon, USA) for 40 min in KRH medium at 37 °C. After rinsing in KRH to remove extracellular Fura-2, the cover glasses were mounted as the bottom of an open chamber (Larsson-Nyrén & Sehlin 1996). Experiments were performed using an image analysis system Openlab (Improvision, Coventry, West Midlands, UK) on an inverted microscope (Zeiss Axiovert, Gottingen, Germany) equipped for epifluorescence measurements. The cells were continuously perifused at a flow rate of 0.6 ml/min. The diameter of the perifusion chamber was 5 mm and volume of fluid in the chamber during perifusion was ~80 µl, which means that the whole volume was replaced within 8 s. The inflow tube was mounted close to the bottom at a distance of 1 mm from the center of the chamber.
Fura-2 was successively excited at the wavelengths 340 and 380 nm during 23 ms each using a 75 W Xenon lamp and a Polychrome IV monochromator (TILL Photonics, Murtinsried, Germany). The interval between cycles of 340 and 380 nm excitation was 1.75 s. Images were acquired by a camera (Orca ER, Hamamatsu, Japan). Temperature control (37 °C) was obtained by heating the chamber holder and the objective separately. The Ca2+ response was recorded from single ß-cells without direct contact with other cells. ß-Cells were initially preperifused at 3 mM glucose for 15 min. They were then stimulated twice with 100, 20 µM tolbutamide (Hoechst, Frankfurt, Germany), or 10 mM arginine during 10 min with a resting period of 30 min at 3 mM glucose between stimulations. All test media contained 3 mM glucose except in studies with 20 µM tolbutamide, which was applied in KRH medium containing 5 mM glucose to increase the number of responding cells (Jonkers et al. 2001). The duration of stimulation and the resting period were chosen to minimize time-dependent effects after the first stimulation (Nesher et al. 1989), but with sufficient time to recognize individual profiles also from cells that respond late (Larsson-Nyrén et al. 2002, Pakhtusova et al. 2003). Before the second stimulation, the exposed cell was checked by visual inspection. [Ca2+]i was calculated from the ratio of 340 and 380 nm signals after background subtraction using the equation described by Grynkiewicz et al.(1985), with a Kd of 224 nM.
Lag-time for [Ca2+]i rise during the first and second stimulation (LTr1 and LTr2) was defined as the time from the addition of stimulus to the first [Ca2+]i value above baseline average, calculated during the 3 min preceding the stimulation. Peak height during the first and second stimulation (PH1 and PH2) was calculated as the difference between the baseline and the highest [Ca2+]i value during the first peak. Superimposed spikes on top of the peaks were not included in calculations of peak height.
Insulin secretion measurements
ß-Cells were prepared as described above. Zn2+ images with FluoZin-3 (Molecular Probes Inc.) wereacquiredwith 488 nm excitation and 510 nm emission using the Openlab image analysis system on the Zeiss Axiovert microscope (see Measurements of cytoplasmic Ca2+ in ß-cells with Fura2). Buffer with a reduced background Zn2+ level was made as described by Qian et al.(2003). Briefly, KRH was prepared with all ingredients except calcium and magnesium salts. The buffer was then treated with 5 g/dl Chelex-100 (Bio-Rad) for 2 h. The pH was adjusted to 7.4 after Chelex treatment and puratronic grade CaCl2 and MgSO4 (Alfa Aesar, Karlsruhe, Germany) were added to the final concentrations. Glass containers were avoided to minimize metal contamination. The Zn2+ chelator 200 nM tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN; Molecular Probes Inc.) was added. Glass slides for cell preparation were soaked in 2 mM EDTA for 24 days to minimize Zn2+ leaching during the experiments (Kay et al. 2004). Cover glasses with Fura-2 loaded cells were washed in 3 ml KRH containing 2 µM FluoZin-3 and then placed at the bottom of the open chamber and transferred to the microscope. KRH with FluoZin-3 (150 µl) was added to the chamber. To stimulate cells, 10 µl tolbutamide stock solution containing 2 µM FluoZin-3 were added to give a final concentration of 100 µM tolbutamide. Preliminary experiments showed that the final homogeneous concentration of the stimulator in the chamber was reached within 5 s. For controls, KRH buffer without tolbutamide was applied to the cells. FluoZin-3 fluorescence images were collected every 2 s and the average fluorescence intensities were measured after background subtraction in a region of interest (ROI) of ~20 µm around the cell periphery. Cells were identified by differential interference contrast (DIC) images before the measurement and by the low ZnFluozin background from the cell membrane. FluoZin-3 does not penetrate into the cell, presumably because of the three negative charges on the molecule at physiological pH (Gee et al. 2002, Kay et al. 2004). Cells were stimulated during 10 min, after which they were washed by perifusion with KRH containing 3 mM glucose during 30 min. Then, the cells were stimulated again, and [Ca2+]i was measured as described above. The microscope system does not allow a change of excitation exposure during simultaneous measurements. Therefore, attempts were not made to measure Zn2+ efflux and Ca2+ response simultaneously, because Zn2+ measurements required higher excitation intensity than calcium measurements with Fura-2. The wavelengths used for calcium measurements (380 and 340 nm) can be harmful for cells during intense exposure.
Confocal microscopy and measurements of cytoplasmic Ca2+ with Fluo-3
Experiments were performed using the Leica SP2 spectral laser scanning confocal microscopy system (Leica Microsystems, Mannheim, Germany). Measurements were performed with the technique similar to that described by Nadal et al.(1999). Intact islets were loaded with the calcium dye Fluo-3 for 90 min at room temperature and then placed on coverslips on the bottom of an open perifusion chamber always in the same part of the chamber close to the inflow tube. The chamber was put on the stage of the microscope and maintained at 37 °C. Islets were continuously superfused at a flow rate of 0.6 ml/min. Cells were first visualized using transmission laser scanning microscopy. Fluo-3 was excited with the 488 nm line of an argon laser. Fluo-3 responses were recorded from peripheral cells in one randomly chosen cross-section in islets using a Leica x40 oil immersion lens with numerical aperture 1.3. The pinhole was optimized for the x40 objective. The resulting fluorescence was recorded in a channel set up to detect emitted light in the range 510600 nm. Islets were stimulated twice with 20 µM tolbutamide as described above. Images were collected at 2-s intervals, and fluorescence signals from individual cells were measured as a function of time by using the Leica Confocal Software (Heidelberg, Germany) package. Each image frame was examined to adjust the regions of interest for slight movements in cellular location. Images were analyzed and results were plotted using Leica Confocal Software. Fluo-3 is a nonratiometric dye and the fluorescence intensity varies with even minor experimental change. The calcium-dependent change in fluorescence is therefore expressed as arbitrary units.
Chemicals
Collagenase type I, HEPES, and poly-L-lysine were purchased from Boehringer (Mannheim, Germany). BSA, fraction V, EGTA, arginine and DNAase were all from Sigma Chemical Co. Culture medium RPMI 1640 was obtained from Gibco, and fetal calf serum was from Labkemi AB (Stockholm, Sweden). Benzylpenicillin and garamycin were from Schering Co. (Kenilworth, NJ, USA). Tolbutamide was from Hoechst AG (Frankfurt, Germany). Fura 2-AM, Fluo-3, FluoZin-3, and TPEN were from Molecular Probes Inc. (Eugene, OR, USA). Puratronic CaCl2 and MgSO4 were from Alfa Aesar (Karlsruhe, Germany). All other reagents were of analytical grade.
Statistical analysis
The data are presented as means±S.E.M. Comparisons of responses from the same cell during first and second stimulation were made using Students t-test for paired data and calculated correlation coefficients (Pearson correlation). The linear representative of the correlation was calculated using the least square method. For comparison between sets of experiments, two-tailed Students t-test for independent data was used. The significance limit was set at P<0.05.
| Results |
|---|
|
|
|---|
Responses were most often registered in cells situated close to the center of the chamber. Control experiments have shown no differences in lag time for [Ca2+]i rise in cells situated in the central area and on the periphery of the chamber when cells were stimulated with high glucose (133±24 s (n=7) vs 158±21 s (n=12) respectively).
The average lag time for tolbutamide-induced [Ca2+]i rise is shorter than that for the response to glucose and unlike glucose, tolbutamide causes no initial lowering in [Ca2+]i (Grapengiesser et al. 1988). We tested 100 µM, which gives near maximal stimulation and 20 µM tolbutamide to find out if the lag time is concentration dependent. The lower concentration may provide more heterogeneous responses with regard to timing and reduce the risk for persisting effects that may influence the second response. Tolbutamide at 20 µM induced no response in most cells when tested together with 3 mM glucose (data not shown). Therefore, the glucose concentration was increased to 5 mM to increase the number of responding cells (Frederickson & Bush 2001). The lag time for calcium rise was longer with 20 µM than with 100 µM tolbutamide during the first stimulation in lean and ob/ob mouse ß-cells (Table 1
, P
<0.001 for lean mouse, P<0.005 for ob/ob mouse, P=0.11 for db/db mouse ß-cells). Timing of the response was cell-specific in ß-cells from lean but not from ob/ob or db/db mice both with 100 and 20 µM (Table 1
). The lag time was shorter in db/db mouse ß-cells than in lean mouse ß-cells (Table 1
). ß-Cells from ob/ob mice also reacted more promptly to stimulation with 100 µM tolbutamide than lean mouse ß-cells.
|
|
|
Arginine induced cell-specific Ca2+ responses in lean mouse ß-cells with regard to both timing and magnitude (Table 1
). There was no correlation between lag times for calcium rise during the first and second stimulation in ß-cells from db/db or ob/ob mice but peak heights were cell-specific in db/db mouse ß-cells (Table 1
). As with tolbutamide, the response in db/db mouse ß-cells occurred with shorter lag times than in lean mouse ß-cells and reached a lower magnitude.
Cell specificity of the insulin secretion in isolated ß-cells
We have also tested to what extent temporal cell specificity of the Ca2+ response is related to insulin release. Zn2+ is co-released with insulin and Zn2+ efflux was measured as a marker of insulin secretion (Frederickson & Bush 2001, Qian et al. 2003). The secretory response to 100 µM tolbutamide was recorded during the first stimulation and the Ca2+ response was recorded during the second stimulation (Fig. 3A
). We found that the time of onset of the Zn2+ outflow correlated with the lag time for calcium rise in lean mouse ß-cells (Table 1
, Fig. 3B
) but not in ob/ob mouse ß-cells (Table 1
, Fig. 3C
). We have not compared the magnitudes of Zn2+ and Ca2+ response because Zn2+ dissolves quickly in the surrounding medium and the rise in Zn2+ outflow is difficult to estimate.
|
We studied responses from individual ß-cells on the periphery of Fluo-3-labeled intact islets (Fig. 4A
) during two consecutive stimulations. Tolbutamide at 20 µM was chosen as the stimulus to get a larger variation in lag time for Ca2+rise. We tested 30 cells in six lean mouse islets and 87 cells in ten ob/ob mouse islets. Parameters were calculated as described for isolated ß-cells. ß-Cells within lean mouse islets showed cell-specific responses with a high degree of correlation between lag times during the first and second stimulation (Fig. 4C
). Figure 4B
shows representative traces from two cells. Within each islet, there was often only a small difference in lag time among individual cells and between the first and second stimulation (Table 1
). PH1 and PH2 were correlated, but PH2 was lower than PH1 (Table 1
). A lower PH2 could be due to dye degradation and/or leakage. However, we previously recorded a lower second response to glucose also using Fura-2 in intact islets (Pakhtusova et al. 2003).
|
| Discussion |
|---|
|
|
|---|
1-subunit of L-type Ca2+ channels was observed in the Zucker diabetic fatty rat (Roe et al. 1996). Other studies report an increased activity of L-type Ca2+ channels in the Goto Kakisaki rat (Kato et al. 1996). A lower expression of Ca2+ channels could possibly explain the reduced Ca2+ response but not the loss of temporal cell specificity, which we found in db/db and ob/ob mouse ß-cells. This indicates that other alterations of Ca2+ channels are present in ß-cells hyperglycemic mice. The failure of db/db and ob/ob mouse ß-cells to show cell-specific timing of response to a KATP-channel blocker (tolbutamide) may be due to increased activity of KATP channels and impaired electrical activity (Ashcroft & Rorsman 2004). The cell-specific magnitude of the response to tolbutamide in ß-cells from hyperglycemic mouse indicates that timing and magnitude of the Ca2+ response are controlled by different mechanisms.
Type-2 diabetic ß-cells show a delayed Ca2+ response to glucose but not to arginine or sulfonylureas (Zaitsev et al. 1997, Del Guerra et al. 2005). In fact ß-cells from db/db mice responded to tolbutamide and arginine with a shorter lag time than lean mouse ß-cells and a similar tendency was found also in ob/ob mouse ß-cells. The magnitude of the response was lower in db/db mouse ß-cells with both nutrient (Roe et al. 1994, Gustavsson et al. 2005) and non-nutrient stimulators (this report). It may be that chronic hyperglycemia slows down the metabolic rate but increases the sensitivity of K+ATP or Ca2+ channels (Kato et al. 1996).
The lag time for Ca2+ rise was longer in response to 20 µM tolbutamide when compared with 100 µM, but the magnitudes of response and the patterns of [Ca2+]i changes were similar. There have been no studies aimed at comparing the timing of ß-cell depolarization when different concentrations of sulfonylureas are used. However, in the paper by Henquin (1998), recordings of electrical responses to 15, 25, and 100 µM tolbutamide were shown. From the data, it appears that the depolarization is slower with 15 µM, but does not differ between 25 and 100 µM tolbutamide (Henquin 1998). The longer lag time for calcium rise to 20 µM tolbutamide is therefore likely to be caused by a slower depolarization. The difference is probably not related to the difference in glucose concentration in the stimulatory solution, because an increase in glucose concentration would induce a quicker response.
The peak height during the second stimulation was smaller in ob/ob mouse ß-cells than in lean mouse cells (Table 1
). Cells may be desensitized by the previous exposure to sulfonylureas (McClenaghan et al. 2000), but it is difficult to explain the fact that only mice with a milder hyperglycemic syndrome but not severely diabetic mice develop the desensitization.
The timing of Zn2+ outflow recorded during the first stimulation with tolbutamide in lean mouse ß-cells correlated with the timing of Ca2+response recorded during the second stimulation. We showed that ß-cells repeat their Ca2+ response pattern during consecutive stimulations with tolbutamide. It has also been found that cytoplasmic calcium changes and Zn2+release are linked with regard to both timing and magnitude (Qian et al. 2004). With the assumption that the timing of insulin release is correlated to the lag time for Ca2+ response also during consecutive stimulations we can, therefore, conclude that the timing of insulin release to tolbutamide is cell-specific in normal mouse ß-cells. No such correlation was found in ob/ob mouse ß-cells. Most likely, this is coupled to the lack of cell specificity for Ca2+ responses to tolbutamide.
It was recently claimed that cells within an islet show identical temporal responses (Kuznetsov et al. 2005). We could identify fast and slow responding cells within both lean and ob/ob mouse islets. The variation was rather small in lean mouse islets, but in ob/ob mouse islets the range of lag times was almost as large as in isolated ß-cells. This could be due to a disturbed stimulussecretion coupling or to a damage of cell contacts and may explain the disorganization of [Ca2+]i oscillations found in ob/ob mouse islets (Ravier et al. 2002). ß-Cells both within intact lean and ob/ob mouse islets showed cell-specific timing of their Ca2+ responses to tolbutamide. Thus, cell-specific timing of response to tolbutamide can be observed in functionally coupled, but not in isolated ß-cells from ob/ob mice. This supports the hypothesis that some ß-cells have a pacemaker function. ß-Cells may vary in their functional characteristics, because ß-cells within pancreatic islets originate not from a single stem cell but from a number of different low-differentiated precursors (Lechner & Habener 2003). We have previously reported that intact islets as a whole show a specific response (Pakhtusova et al. 2003). Taken together, this indicates that both the cell specificity of each ß-cell and the functional connection between cells is important for islet-specific behavior and adequate insulin release.
Normal ß-cells show cell-specific responses with all tested stimuli. ß-Cells from hyperglycemic mice have shown cell-specific timing and magnitude of responses to glucose and glyceraldehyde, but they have lost their temporal cell specificity when stimulated with a mitochondrial substrate, which suggested an altered mitochondrial function (Gustavsson et al. 2005). The loss of cell-specific timing of response also at the step of Ca2+ channel opening suggests that the mechanism(s) for setting the individual response characteristics is impaired in diabetic mouse ß-cells. Therefore, cell specificity for all steps of the stimulussecretion coupling may be important for normal function.
ß-Cells constitute more than 90% of the cells islet ob/ob mice and about 70% in normal mouse islets. The proportion of ß-cells in islets from severely diabetic mice is reduced (Baetens et al. 1978). Therefore, it is possible that many of the cultured cells were non-ß-cells in the latter two mouse models. However, cells included in this study showed [Ca2+]i responses to tolbutamide, tolbutamide in combination with glucose, and arginine that were all typical for ß-cells (Berts et al. 1996, Quesada et al. 1999).
In conclusion, normal ß-cells show cell-specific Ca2+ responses when stimulated with nonmetabolic agents. The lag time is not cell-specific in tolbutamide- and arginine-stimulated isolated ß-cells from hyperglycemic mice. Cell specificity seems to be a robust mechanism, which is probably necessary for an adequate ß-cell function.
| Acknowledgements |
|---|
| References |
|---|
|
|
|---|
Ashcroft F & Rorsman P 2004 Type 2 diabetes mellitus: not quite exciting enough? Human Molecular Genetics 13 (Spec No 1) R21R31.
Baetens D, Stefan Y, Ravazzola M, Malaisse-Lagae F, Coleman DL & Orci L 1978 Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 27 17.[Abstract]
Berglund O, Frankel BJ & Hellman B 1978 Development of the insulin secretory defect in genetically diabetic (db/db) mouse. Acta Endocrinologica 87 548551.
Berts A, Ball A, Gylfe E & Hellman B 1996 Suppression of Ca2+ oscillations in glucagon-producing alpha 2-cells by insulin/glucose and amino acids. Biochimica et Biophysica Acta 1310 212216.[Medline]
Cerasi E, Luft R & Efendic S 1972 Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes 21 224234.[ISI][Medline]
Charles S, Tamagawa T & Henquin J-C 1982 A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids. Biochemical Journal 208 301308.[ISI][Medline]
Del Guerra S, Lupi R, Marselli L, Masini M, Bugliani M, Sbrana S, Torri S, Pollera M, Boggi U, Mosca F, Del Prato S & Marchetti P 2005 Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54 727735.
Frederickson CJ & Bush AI 2001 Synaptically released zinc: physiological functions and pathological effects. Biometals 14 353366.[CrossRef][ISI][Medline]
Gee KR, Zhou ZL, Qian WJ & Kennedy R 2002 Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator. Journal of the American Chemical Society 124 776778.[CrossRef][ISI][Medline]
Grapengiesser E, Gylfe E & Hellman B 1988 Dual effect of glucose on cytoplasmic Ca2+ in single pancreatic beta-cells. Biochemical and Biophysical Research Communications 150 419425.[CrossRef][ISI][Medline]
Grynkiewicz G, Poenie M & Tsien RY 1985 A new generation of Ca2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 260 34403450.
Gustavsson N, Larsson-Nyrén G & Lindström P 2005 Pancreatic ß-cells from db/db mice show cell-specific [Ca2+]i and NADH responses to glucose but not to alpha-ketoisocaproic acid. Pancreas 31 242250.[CrossRef][ISI][Medline]
Hellman B, Idahl L-Ä, Lernmark Ä, Sehlin J & Täljedal I-B 1974 The pancreatic beta-cell recognition of insulin secretagogues. Effects of calcium and sodium on glucose metabolism and insulin release. Archives of Biochemistry and Biophysics 162 448457.[CrossRef][ISI][Medline]
Hellman B, Dansk H & Grapengiesser E 2004 Pancreatic beta-cells communicate via intermittent release of ATP. American Journal of Physiology Endocrinology and Metabolism 286 E759E765.
Henquin J-C 1998 A minimum of fuel is necessary for tolbutamide to mimic the effects of glucose on electrical activity in pancreatic beta-cells. Endocrinology 139 993998.
Herchuelz A, Lebrun P, Boschero AC & Malaisse WJ 1984 Mechanism of arginine-stimulated Ca2+ influx into pancreatic B cell. American Journal of Physiology 246 E38E43.[Medline]
Herchuelz A, Pochet R, Pastiels C & Van Praet A 1991 Heterogeneous changes in [Ca2+]i induced by glucose, tolbutamide and K+ in single rat pancreatic B cells. Cell Calcium 12 577586.[CrossRef][ISI][Medline]
Idahl L-Ä, Lernmark Ä , Sehlin J & Täljedal I-B 1976 Studies on the function of pancreatic islet cell membranes. Journal of Physiology 72 729746.
Jonkers FC, Guiot Y, Rahier J & Henquin J-C 2001 Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca(2+) response. British Journal of Pharmacology 133 575585.[CrossRef][ISI]
Kato S, Ishida H, Tsuura Y, Tsuji K, Nishimura M, Horie M, Taminato T, Ikehara S, Odaka H, Ikeda I et al. 1996 Alterations in basal and glucose-stimulated voltage-dependent Ca2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats. Journal of Clinical Investigation 97 24172425.[ISI][Medline]
Kay AR et al. 2004 Detecting and minimizing zinc contamination in physiological solutions. BMC Physiology 4 4.[CrossRef][Medline]
Kuznetsov A, Bindokas VP, Marks JD & Philipson LH 2005 FRET-based voltage probes for confocal imaging: membrane potential oscillations throughout pancreatic islets. Americal Journal of Physiology Cell Physiology 289 C224C229.
Larsson-Nyrén G & Sehlin J 1996 Comparison of the effects of perchlorate and Bay K 8644 on the dynamics of cytoplasmic Ca2+ concentration and insulin secretion in mouse ß-cells. Biochemical Journal 314 167173.
Larsson-Nyrén G, Pakhtusova N & Sehlin J 2002 Isolated mouse pancreatic beta-cells show cell-specific temporal response pattern. American Journal of Physiology Cell Physiology 282 C1199C1204.
Lechner A & Habener JF 2003 Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. American Journal of Physiology Endocrinology and Metabolism 284 E259E266.
Lernmark Ä 1974 The preparation of and studies on free cell suspensions from mouse pancreatic islets. Diabetologia 10 431438.[CrossRef][ISI][Medline]
McClenaghan NH, Ball AJ & Flatt PR 2000 Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide. British Journal of Pharmacology 30 478484.[CrossRef]
Nadal A, Quesada I & Soria B 1999 Homologous and heterologous asynchronicity between identified alpha-, beta- and delta-cells within intact islets of Langerhans in the mouse. Journal of Physiology 517 8593.
Nesher R, Eylon L, Segal N & Cerasi E 1989 Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas. Endocrinology 124 142148.[Abstract]
Pakhtusova N, Zaostrovskaya L, Lindström P & Larsson-Nyrén G 2003 Cell-specific Ca(2+) responses in glucose-stimulated single and aggregated beta-cells. Cell Calcium 34 121129.[CrossRef][ISI][Medline]
Pipeleers D, Kiekens R, Ling Z, Wilikens A & Schuit F 1994 Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 37 (Suppl 2) 5764.
Porte D Jr 1991 ß-Cells in type II diabetes mellitus. Diabetes 40 166180.[Abstract]
Pralong WF, Bartley C & Wollheim CB 1990 Single islet beta-cell stimulation by nutrients: relationship between pyridine nucleotides, cytosolic Ca2+and secretion. EMBO Journal 9 5360.[ISI][Medline]
Qian WJ, Gee KR & Kennedy RT 2003 Imaging of Zn2+ release from pancreatic beta-cells at the level of single exocytotic events. Analytical Chemistry 75 34683475.[Medline]
Qian WJ, Peters JL, Dahlgren GM, Gee KR & Kennedy RT 2004 Simultaneous monitoring of Zn2+ secretion and intracellular Ca2+ from islets and islet cells by fluorescence microscopy. Biotechniques 37 922924, 926, 928930 passim.[ISI][Medline]
Quesada I, Nadal A & Soria B 1999 Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes 48 23902397.[Abstract]
Ravier MA, Sehlin J & Henquin J-C 2002 Disorganization of cytoplasmic Ca(2+) oscillations and pulsatile insulin secretion in islets from ob/ob mice. Diabetologia 45 11541163.[CrossRef][ISI][Medline]
Roe MW, Philipson LH, Frangakis CJ, Kuznetsov A, Mertz RJ, Lancaster ME, Spencer B, Worley JF 3rd & Dukes ID 1994 Defective glucose-dependent endoplasmic reticulum Ca2+sequestration in diabetic mouse islets of Langerhans. Journal of Biological Chemistry 269 1827918282.
Roe MW, Worley JF 3rd, Tokuyama Y, Philipson LH, Sturis J, Tang J, Dukes ID, Bell GI & Polonsky KS 1996 NIDDM is associated with loss of pancreatic beta-cell L-type Ca2+ channel activity. Americal Journal of Physiology 270 E133E140.
Salomon D & Meda P 1986 Heterogeneity and contact-dependent regulation of hormone secretion by individual ß cells. Experimental Cell Research 162 507520.[CrossRef][ISI][Medline]
Trube G, Rorsman P & Ohno-Shosaku T 1986 Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Archive 407 493499.
Zaitsev S, Efanova I, Ostenson CG, Efendic S & Berggren PO 1997 Delayed Ca2+ response to glucose in diabetic GK rat. Biochemical and Biophysical Research Communications 239 129133.[CrossRef][ISI][Medline]
Received in final form 10 April 2006
Accepted 25 April 2006
Made available online as an Accepted Preprint 10 May 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |